Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.
2.

Population benefits of cholesterol reduction: epidemiology, economics, and ethics.

Pearson TA.

Am J Cardiol. 2000 Jun 22;85(12A):20E-3E. Review.

PMID:
10858490
3.
4.

Expanding roles for atorvastatin.

Singh V, Deedwania P.

Drugs Today (Barc). 2008 Jun;44(6):455-71. doi: 10.1358/dot.2008.44.6.1217468. Review.

PMID:
18596999
6.

Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.

Stone NJ, Bilek S, Rosenbaum S.

Am J Cardiol. 2005 Aug 22;96(4A):53E-59E. Review.

PMID:
16098845
7.

Efficacy of drug intervention for lipids in the prevention of coronary artery disease.

Howes LG, Simons LA.

Aust N Z J Med. 1994 Feb;24(1):107-12. Review.

PMID:
8002848
8.

[Intensive cholesterol lowering therapy to reduce cardiovascular risk].

Rigotti R A, Arteaga Ll A, Maiz G A.

Rev Med Chil. 2006 May;134(5):641-8. Epub 2006 Jun 19. Review. Spanish.

9.

Expected versus observed survival in 3 large population studies with HMG-CoA reductase inhibitors.

Naslafkih A, Sestier F.

J Insur Med. 2000;32(3):155-62. Review.

PMID:
15912915
10.

[Statins in stroke prevention].

Gedikli O, Baykan M.

Anadolu Kardiyol Derg. 2008 Jun;8(3):217-22. Review. Turkish.

11.

Lipid management and the elderly.

Davidson MH, Kurlandsky SB, Kleinpell RM, Maki KC.

Prev Cardiol. 2003 Summer;6(3):128-33; quiz 134-5. Review.

12.

Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke.

Ueshima H.

J Atheroscler Thromb. 2007 Dec;14(6):278-86. Epub 2007 Dec 17. Review.

14.
15.

Statins and diabetes.

Carmena R, Betteridge DJ.

Semin Vasc Med. 2004 Nov;4(4):321-32. Review.

PMID:
15861314
16.

Effect of lipid modification on progression of coronary calcification.

McCullough PA.

J Am Soc Nephrol. 2005 Nov;16 Suppl 2:S115-9. Review.

17.

The pharmacoeconomic benefits of cholesterol reduction.

Gonzalez ER.

Am J Manag Care. 1998 Feb;4(2):223-30. Review.

18.
19.

[A new approach to the treatment of dyslipidemia].

Kevelaitiene S, Slapikas R.

Medicina (Kaunas). 2008;44(5):407-13. Review. Lithuanian.

20.

Low-density lipoprotein in the setting of congestive heart failure: is lower really better?

Horwich T.

Curr Atheroscler Rep. 2009 Sep;11(5):343-9. Review.

PMID:
19664377

Supplemental Content

Support Center